The Effects of Cardiometabolic Comorbidities on Biologic Treatment for Psoriasis with Respect to PASI Scores: A Qualitative Systematic Review
Alim Osman, Alexandra Nigro, Amanda Chen Taylor, Ryan Saal, Ana Ormaza Vera, Clinton Enos Department of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USACorrespondence: Alim Osman, Department of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USA, Email osmana@evms.eduObjecti...
Saved in:
Main Authors: | Osman A (Author), Nigro A (Author), Taylor AC (Author), Saal R (Author), Ormaza Vera A (Author), Enos C (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PASI and PQOL-12 score in psoriasis : Is there any correlation?
by: Vikas Shankar, et al.
Published: (2011) -
Clinical evaluation of different therapeutic modalities in psoriasis by Pasi score
by: Neerja Puri, et al.
Published: (2013) -
comment: Clinical evaluation of different therapeutic modalities in psoriasis by Pasi score
by: Hisayoshi Imanishi, et al.
Published: (2013) -
History of diabetes is associated with reduced likelihood of achieving PASI75 and PASI90 at 12 months among psoriasis patients treated with biologics: A prospective analysis in the CorEvitas Psoriasis Registry
by: Clinton W. Enos, MD, MS, et al.
Published: (2024) -
Cardiometabolic Comorbidities in Patients With Psoriasis: Focusing on Risk, Biological Therapy, and Pathogenesis
by: Jiangluyi Cai, et al.
Published: (2021)